Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava
- PMID: 3683595
- DOI: 10.1007/BF00172673
Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava
Abstract
In the rat inferior vena cava preincubated with 3H-noradrenaline, the effects of nine serotonin (5-HT) receptor agonists and of eight antagonists (including two beta-adrenoceptor blocking agents) on the electrically evoked 3H overflow were determined. 1. 5-HT, 5-carboxamido-tryptamine, 5-methoxy-3(1,2,3,6-tetrahydropyridine-4-yl)-1H-indole (RU 24969), 5-methoxytryptamine, N,N-dimethyl-5HT, tryptamine and 5-aminotryptamine inhibited the evoked 3H overflow. The potencies of these agonists in inhibiting overflow were significantly correlated with their affinities for 5-HT1B binding sites, but not with their affinities for 5-HT1A, 5-HT1C or 5-HT2 binding sites. 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a 5-HT1A receptor agonist, and ipsapirone, a partial agonist at these receptors, did not inhibit overflow. 2. Cyanopindolol facilitated the evoked 3H overflow, an effect which was abolished by propranolol. The maximum inhibition of overflow obtainable with 5-HT was diminished by cyanopindolol. 3. The concentration-response curve for 5-HT was shifted to the right by metitepine, metergoline, quipazine, 6-chloro-2-(1-piperazinyl)pyrazine (MK 212) and propranolol which, given alone, did not affect 3H overflow. The apparent pA2 values of these antagonists tended to be correlated with their affinities for 5-HT1B (but not 5-HT1A, 5-HT1C or 5-HT2) binding sites. Ketanserin, a 5-HT2 receptor antagonist, and spiperone, which blocks 5-HT2 and 5-HT1A but not 5-HT1B or 5-HT1C receptors, failed to antagonize the effect of 5-HT.(ABSTRACT TRUNCATED AT 250 WORDS)
References
-
- Br J Pharmacol. 1976 May;57(1):115-25 - PubMed
-
- Naunyn Schmiedebergs Arch Pharmacol. 1986 Oct;334(2):156-65 - PubMed
-
- Naunyn Schmiedebergs Arch Pharmacol. 1986 Feb;332(2):124-30 - PubMed
-
- Naunyn Schmiedebergs Arch Pharmacol. 1986 Aug;333(4):335-41 - PubMed
-
- Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):36-44 - PubMed